Vivo Bio Tech — 360° view

Vivo Bio Tech, a company in the Biotechnology industry, reported revenue of ₹17 crore and net profit of ₹1.10 crore for the September 2026 quarter.

Vivo Bio Tech (NSE: VIVOBIOT) closed at ₹16.01 on 20 Nov 2026. Its market capitalisation is ₹36 crore.

Share price
₹16.01 (20 Nov 2026)
Market cap
₹36 Cr (20 Nov 2026)
Revenue
₹17 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
7.74% (FY26)
ROE
-2.24% (FY26)
Book value
₹42.6 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹20.44 / ₹12.00 (20 Nov 2026)
Sector
Healthcare
Industry
Biotechnology
Symbol
NSE: VIVOBIOT

Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.